US Patent 7098303 Conserved motif of hepatitis C virus E2/NS1 region
Patent 7098303 was granted and assigned to Novartis on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Amy J. Weiner0
Michael Houghton0
Edits on 29 Aug, 2023
Golden AI
Edits made to:
Article (+387 characters)
Article
Patent abstract
Immunogenic polypeptides comprising hepatitis C virus (HCV) immunogens are described. The HCV immunogen comprises the amino acid sequence Xaa-Thr-Xaa-Val-Thr-Gly-Gly-Xaa-Ala-Ala-Arg-Thr-Thr-Xaa-Gly-Xaa-Xaa-Ser-Leu-P he-Xaa-Xaa-Gly-Xaa-Ser-Gln-Xaa-Ile-Gln-Leu-Ile (SEQ ID NO:8). The immunogenic polypeptide can be coupled to a bacterial toxoid, such as a diphtheria toxoid.
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07098303 Conserved motif of hepatitis C virus E2/NS1 region US Patent 7098303 Conserved motif of hepatitis C virus E2/NS1 region
Infobox
Patent Number
070983030
Patent Number
70983030
Edits on 31 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
070983030
Date of Patent
August 29, 2006
0Patent Application Number
084379520
Date Filed
May 9, 1995
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 17 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07098303 Conserved motif of hepatitis C virus E2/NS1 region
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07098303
Date of patent
August 29, 2006
Patent application number
08437952
Date Filed
May 9, 1995
Patent primary examiner
Find more entities like US Patent 7098303 Conserved motif of hepatitis C virus E2/NS1 region
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
